Journals / Mikrobiyoloji Bülteni / 2008 / Cilt: 42 - Sayı: 2

Determination of in vitro susceptibility of candida species to amphotericin B by E-test and previously proposed mic breakpoınts on two different media

Candida türlerinin amfoterisinin B'ye duyarlılığının E-test ve iki farklı besiyeri ile önerilmiş olan direnç sınır değerlerine göre araştırılması

Pages
293–300
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusively, according to the previously proposed MIC breakpoints for amphotericin B E-test on RPG and AM3, discrepancies between susceptibility categories of Candida species were of remarkable significance.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although much work has concentrated on defining a reliable and reproducible method for determining in vitro susceptibility of Candida species to amphotericin B, there still has been limitations of the proposed techniques.
📊
Key Findings & Data:In this study, amphotericin B minimal inhibitory concentrations (MIC) and susceptibility categories of 212 Candida strains (57 C.glabrata, 53 C.lusitaniae, 51 C.krusei and 51 C.tropicalis) were determined by E-test on RPMI agar (RPG) and antibiotic medium 3 agar (AM3) both supplemented with 2% glucose.
💡
Conclusion & Impact:Conclusively, according to the previously proposed MIC breakpoints for amphotericin B E-test on RPG and AM3, discrepancies between susceptibility categories of Candida species were of remarkable significance.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Although much work has concentrated on defining a reliable and reproducible method for determining in vitro susceptibility of Candida species to amphotericin B, there still has been limitations of the proposed techniques. In this study, amphotericin B minimal inhibitory concentrations (MIC) and susceptibility categories of 212 Candida strains (57 C.glabrata, 53 C.lusitaniae, 51 C.krusei and 51 C.tropicalis) were determined by E-test on RPMI agar (RPG) and antibiotic medium 3 agar (AM3) both supplemented with 2% glucose. The results were interpreted according to the proposed MIC breakpoints (>0.38 (xg/ml on RPG, >1 jig/ml on AM3) and discrepancies between susceptibility categories were investigated. While all Candida strains included in the study were determined to be susceptible on AM3 by amphotericin B E-test at 48h, 36.3% of the isolates were classified as resistant on RPG at 48 hours. On RPG, C.krusei strains showed the highest resistance rate (94.1% at 48 h), followed by C.tropicalis (35.3% at 48 h) and C.glabrata (17.5% at 48h). At 48h of incubation, 98.1% of C.lusitaniae isolates were found to be susceptible on RPG. The categorical agreement rates between the results obtained on two media and for C.lusitaniae and C.glabrata were 98.1% and 82.5% at 48 hours. For C.tropicalis and C.krusei, the rates of agreement were 64.7% and 5.9% at 48 hours. Conclusively, according to the previously proposed MIC breakpoints for amphotericin B E-test on RPG and AM3, discrepancies between susceptibility categories of Candida species were of remarkable significance.

Özet

Candida türlerinde amfoterisin B'ye in vitro direncin saptanması ile ilgili teknik sorunlar halen devam etmektedir. Bu çalışmada, 212 Candida suşuriun (57 C.glabrata, 53 C.lusitaniae, 51 C.krusei ve 51 C.tropicalis) amfoterisin B minimum inhibitor konsantrasyon (MİK) değerleri E-test yöntemiyle %2 glukozlu RPM11640 (RPG) agar ve %2 glukozlu antibiyotik medium 3 (AM3) ağarda saptanmış, önceden önerilmiş olan direnç sınır değerlerine göre (RPG ağarda >0.38 |a,g/ml, AM3 ağarda >1 |xg/ml) duyarlılık profilleri belirlenmiş ve her iki besiyerinde elde edilen duyarlılık kategorileri arasındaki uyum oranı hem tüm suşlar için hem de türe göre belirlenmiştir. Çalışmaya dahil edilen izolatların tümü E-test yöntemiyle 48 saat inkübasyonun ardından AM3 besiyerinde amfoterisin B'ye duyarlı bulunurken, RPG besiyerinde %36.3'ü amfoterisin B'ye dirençli bulunmuştur. RPG besiyerinde amfoterisin B'ye direnç oranı C.krusei izolatlarında %94.1, C.tropicalis izolatlarında %35.3, C.glabrata izolatlarında %17.5 olarak saptanırken, C.lusitaniae izolatlarının tamamına yakınının (%98.1) duyarlı olduğu belirlenmiştir. AM3 ve RPG ağarda elde edilen amfoterisin B duyarlılık profilleri arasında 48 saat inkübasyon sonrası C.lusitaniae ve C.glabrata izolatlarında sırasıyla, %98.1 ve %82.5 oranında uyum gözlenirken, uyumun C.tropicaiis'te %64.7, C.krusei'öe ise %5.9 olduğu görülmüştür. Bu bulgular, Candida suşlarında AM3 ve RPG ağarda amfoterisin B E-test için önerilen direnç sınır değerleri dikkate alınarak belirlenen duyarlılık profilleri arasında önemli ölçüde uyuşmazlıkların ortaya çıkabildiğini göstermiştir.

🔖

Cite This Article

ALP, Y., SANCAK, B., ARIKAN, S. (2008). Determination of in vitro susceptibility of candida species to amphotericin B by E-test and previously proposed mic breakpoınts on two different media. Mikrobiyoloji Bülteni, Cilt: 42 - Sayı: 2, 293–300. https://ajindex.com/articles/298913

References (12)

  1. Sterling TR, Gasser RA JR, Ziegler A. Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host. Clin Infect Dis 1996; 23: 187-8
  2. Rex JH, Cooper CR Jr, Merz WG, Galgiani JN, Anaissie EJ. Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob Agents Chemother 1995; 39: 906-9
  3. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994; 32: 2092-8
  4. Chang HC, Chang JJ, Chan SH. et al. Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures. J Clin Microbiol 2001; 39: 1328-33
  5. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard. NCCLS Document M27-A2. 2002. NCCLS/CLSI, Wayne, Pa
  6. Wanger A, Mills K, Nelson PW, Rex JH. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates. Antimicrob Agents Chemother 1995; 39: 2520-2
  7. Pfaller MA, Messer SA. Bolmstrom A. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B. Diagn Microbiol Infect Dis 1998; 32: 223-7
  8. Peyron J, Favel A, Michel-Nguyen A, Gilly M, Regli P, Bolmstrom A. Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest. J Clin Microbiol 2001; 39: 339-42
  9. Clancy CJ, Nguyen MH. Correlation between in vitro susceptibility determined by Etest and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia. Antimicrob Agents Chemother 1999; 43: 1289-90
  10. Park BJ, Arthington-Skaggs BA, Hajjeh RA, et al. Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Antimicrob Agents Chemother 2006; 50: 1287-92. 11.
  11. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50: 243-60
  12. Yang YL, Li SY, Cheng HH, Lo HJ- TSARY Hospitals. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbio